REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 216 filers reported holding REVANCE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $88,319 | -98.4% | 7,700 | -95.4% | 0.00% | -100.0% |
| Q1 2023 | $5,397,365 | -66.3% | 167,568 | -71.3% | 0.01% | -71.0% |
| Q2 2018 | $16,001,000 | -10.9% | 582,900 | 0.0% | 0.03% | +3.3% |
| Q1 2018 | $17,953,000 | -13.8% | 582,900 | 0.0% | 0.03% | -23.1% |
| Q4 2017 | $20,839,000 | +29.8% | 582,900 | 0.0% | 0.04% | +18.2% |
| Q3 2017 | $16,059,000 | +4.4% | 582,900 | 0.0% | 0.03% | -5.7% |
| Q2 2017 | $15,389,000 | +26.9% | 582,900 | 0.0% | 0.04% | +9.4% |
| Q1 2017 | $12,124,000 | +0.5% | 582,900 | 0.0% | 0.03% | -27.3% |
| Q4 2016 | $12,066,000 | +27.7% | 582,900 | 0.0% | 0.04% | +25.7% |
| Q3 2016 | $9,449,000 | +13.8% | 582,900 | -4.5% | 0.04% | +2.9% |
| Q2 2016 | $8,300,000 | -22.1% | 610,300 | 0.0% | 0.03% | -22.7% |
| Q1 2016 | $10,656,000 | -48.9% | 610,300 | 0.0% | 0.04% | -54.2% |
| Q4 2015 | $20,848,000 | +14.8% | 610,300 | 0.0% | 0.10% | +28.0% |
| Q3 2015 | $18,163,000 | – | 610,300 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 4,592,047 | $156,130,000 | 32.47% |
| Camber Capital Management LP | 630,000 | $21,420,000 | 1.40% |
| Granite Point Capital Management, L.P. | 50,000 | $1,700,000 | 1.17% |
| Rhenman & Partners Asset Management AB | 82,000 | $2,788,000 | 0.83% |
| Geduld E E | 25,001 | $850,000 | 0.53% |
| Pier Capital, LLC | 106,985 | $3,637,000 | 0.52% |
| Ghost Tree Capital, LLC | 20,000 | $680,000 | 0.48% |
| ArrowMark Colorado Holdings LLC | 433,457 | $14,738,000 | 0.42% |
| Polar Capital LLP | 577,042 | $19,618,000 | 0.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 256,500 | $8,721,000 | 0.35% |